MELINTA THERAPEUTICS INC's ticker is MLNTQ and the CUSIP is 58549G209. A total of 53 filers reported holding MELINTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.66 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Granahan Investment Management | 222,571 | $1,480,000 | 0.07% |
| BOENNING & SCATTERGOOD, INC. | 22,500 | $149,000 | 0.04% |
| CONDOR CAPITAL MANAGEMENT | 14,000 | $93,000 | 0.01% |
| STIFEL FINANCIAL CORP | 267,666 | $1,780,000 | 0.01% |
| Sculptor Capital LP | 237,000 | $1,576,000 | 0.00% |
| Sculptor Capital LP | 247,000 | $1,642,000 | 0.00% |
| Palo Alto Investors LP | 10,137 | $67,000 | 0.00% |
| Paloma Partners Management Co | 30,800 | $205,000 | 0.00% |
| AlphaMark Advisors, LLC | 780 | $5,000 | 0.00% |
| Renaissance Technologies | 243,932 | $1,622,000 | 0.00% |